Where is Immatics headquartered?

Immatics is located in Tuebingen, baden-württemberg.

Who invested in Immatics?

Immatics has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Immatics?

Immatics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

immatics.com

Immatics

Immatics is a Germany-based clinical-stage biopharmaceutical company that researches and develops T-cell immunotherapies for the treatment of cancer.

Business Model:

Revenue: $39.4M

Employees: 201-500

Geographic Data

Address: Paul-Ehrlich-Str. 15

City: Tuebingen

State: baden-württemberg

Zip: 72076

Country: DE

Financial Info

Stage:

post ipo equity

Raised Last:

$104M

Raised Total:

$446M

Social

Facebook

Twitter

Crunchbase

Metrics

2,196,740Website Global Rank

8,824Website Monthly Traffic

Twitter Followers

Description

Immatics is a Germany-based clinical-stage biopharmaceutical company that researches and develops T-cell immunotherapies for the treatment of cancer.

Contact Phone:

Contact Email:

IPO Details

Immatics went public on 7/2/2020 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/2/2020

Ticker Symbol:
IMTX

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
1/2017	Series E	2	$30M	Amgen Grazia Equity Amgen Amgen Grazia Equity
9/2019	Venture Round	1	$75M	Celgene Celgene
10/2022	Post-IPO Equity		$0	683 CAPITAL Armistice Capital Dellora Investments EcoR1 Capital Nantahala Capital Management Perceptive Advisors Rock Springs Capital RTW Investments Samsara BioCapital SilverArc Capital Sofinnova Investments Wellington Management 683 CAPITAL Armistice Capital Dellora Investments EcoR1 Capital Nantahala Capital Management Perceptive Advisors Rock Springs Capital RTW Investments Samsara BioCapital SilverArc Capital Sofinnova Investments Wellington Management
3/2020	Post-IPO Equity		$0	AT Impf dievini Hopp Biotech Holding Perceptive Advisors Redmile Group RTW Investments LLC Sphera Funds Management Wellington Partners AT Impf dievini Hopp Biotech Holding Perceptive Advisors Redmile Group RTW Investments LLC Sphera Funds Management Wellington Partners
10/2022	Post-IPO Equity		$110M	Armistice Capital Dellora Investments EcoR1 Capital Nantahala Capital Perceptive Advisors Rock Springs Capital RTW Investments Samsara BioCapital SilverArc Capital Sofinnova Investments Wellington Management
10/2013	Series D	3	$16.2M	AT Impf dievini Hopp Biotech Holding Wellington Partners AT Impf dievini Hopp Biotech Holding Wellington Partners
10/2017	Series E	4	$58M	Amgen AT Impf dievini Hopp Biotech Holding Wellington Partners Amgen Amgen AT Impf dievini Hopp Biotech Holding Wellington Partners
2/2004	Series A		$0	3i Group Wellington Partners Merifin Capital VINCI CAPITAL L-Bank Grazia Equity EMBL Ventures 3i Group Wellington Partners Merifin Capital VINCI CAPITAL L-Bank Grazia Equity EMBL Ventures
7/2020	PIPE		$104M	Perceptive Advisors
4/2020	IPO		-
7/2014	Series D		$0	AT Impf dievini Hopp Biotech Holding Wellington Partners AT Impf dievini Hopp Biotech Holding Wellington Partners
2/2007	Series B	7	$52.1M	3i Group DH Capital KfW NTEC OH Beteiligungen Swisscom Ventures Wellington Partners 3i Group DH Capital KfW NTEC OH Beteiligungen Swisscom Ventures Wellington Partners
9/2010	Series C	4	$71.2M	AT Impf dievini Hopp Biotech Holding MIG Capital Wellington Partners AT Impf dievini Hopp Biotech Holding MIG Capital Wellington Partners
4/2020	IPO		-
3/2020	Post-IPO Equity	7	$104M	AT Impf dievini Hopp Biotech Holding Perceptive Advisors Redmile Group RTW Investments LLC Sphera Funds Management Wellington Partners AT Impf dievini Hopp Biotech Holding Perceptive Advisors Redmile Group RTW Investments LLC Sphera Funds Management Wellington Partners
7/2014	Series D	3	$29.8M	AT Impf dievini Hopp Biotech Holding Wellington Partners AT Impf dievini Hopp Biotech Holding Wellington Partners
10/2013	Series D	3	$16.2M	AT Impf dievini Hopp Biotech Holding Wellington Partners AT Impf dievini Hopp Biotech Holding Wellington Partners
9/2010	Series C	4	$71.2M	AT Impf dievini Hopp Biotech Holding MIG Wellington Partners AT Impf dievini Hopp Biotech Holding MIG Wellington Partners
2/2007	Series B	7	$52.1M	3i Group DH Capital KfW NTEC OH Beteiligungen Swisscom Ventures Wellington Partners 3i Group DH Capital KfW NTEC OH Beteiligungen Swisscom Ventures Wellington Partners
2/2004	Series A	7	$9.9M	3i Group Wellington Partners 3i Group Wellington Partners

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details